Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological standardization of grass pollen allergen extracts in sensitized patients
2019-002644-24Phase 2Completed
- Sponsor
- Laboratorios Diater
- Start
- Dec 2019
- Modality
- Small Molecules, Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of allergovac depot, lolium allergen extract, poa pratensis allergen extract, dactylis glomerata allergen extract, grass pollen allergen extract mixture and 1 more in allergic rhinitis (AR) and grass pollen allergy (6 arms), sponsored by Laboratorios Diater. Primary endpoint: Cutaneous reaction to the extracts. Started Dec 2019; status: completed.
02
Drugs
allergovac depotlolium allergen extractpoa pratensis allergen extractdactylis glomerata allergen extractgrass pollen allergen extract mixture
03
Conditions
allergic rhinitis (AR)grass pollen allergy
Beyond the preview
Go deeper on 2019-002644-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002644-24.